What does it mean to be the true “voice of commercial” in oncology, and why does it matter more than ever?

In this episode of Oncology Voice Network Podcast, join Dr. Kirk Shepard as he welcomes Daniel Switzer, Head of U.S. Oncology at Daiichi Sankyo, for a revealing look inside the commercial engine that drives cancer innovation from the lab all the way to the patient. With two decades of leading launches, transformations, and cross-functional teams, Daniel Switzer shares his most pivotal moments, from high-stakes encounters with patients to standing ovations at ASCO Congress.

Discover why commercial is about so much more than sales, how ethical responsibility and clear alignment can truly change outcomes, and what happens when teams get it wrong. Daniel Switzer discusses breaking down silos, building bridges with R&D, and the necessity of early, unified collaboration in launching life-changing therapies. Plus, hear why the Oncology Voice Network and industry-wide learning are the next frontiers in elevating patient care.

Whether you're in pharma, research, or just passionate about innovation, this episode will reframe what commercial leadership means in today’s oncology world.

Tune in now and get inspired to bridge the gaps that matter most.